Author

C. Bodemer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Bader-Meunier· 2 shared A. Belot· 1 shared A. Bouafia· 1 shared A. Dhir· 1 shared A. Lepelley· 1 shared A. Magerus· 1 shared B. Callewaert· 1 shared C. Picard· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Bader-Meunier

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A

A. Lepelley, E. Della Mina, E. Van Nieuwenhove, L. Waumans, S. Fraitag, G. I. Rice, A. Dhir, M.-L. Fremond, M. P. Rodero, L. Seabra, E. Carter, C. Bodemer, D. Buhas, B. Callewaert, P. de Lonlay, , Y. J. Crow

The paper identifies mutations in ATAD3A causing enhanced type I interferon signaling in patients with neurological and autoimmune features.

bioRxiv · Apr 2, 2021Immunology

Heterozygous RELA mutations cause early-onset systemic lupus erythematosus by hijacking the NF-κB pathway towards transcriptional activation of type-I Interferon genes

L. Barnabei, H. Lamrini, M. Castela, N. Jeremiah, M.-C. Stolzenberg, L. Chentout, S. Mirshavalad, A. Bouafia, A. Magerus, M. Moncan, S. Jacques, O. Pelle, V. Bondet, D. Duffy, M. Parisot, , F. Rieux-Laucat

This study identifies heterozygous RELA mutations in early-onset SLE patients, showing they drive type-I interferon gene expression through NF-κB pathway hijacking.

bioRxiv · Apr 27, 2020 · PreprintImmunology